Paying the right price for pharmaceuticals: A case study of why the comparator matters

Jean Spinks, Jeffrey Richardson

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)


This article considers the pricing policy for pharmaceuticals in Australia, which is widely seen as having achieved low drug prices. However, compared to New Zealand, the evidence implies that Australia might have improved its performance significantly if it had proactively sought market best pricing. The Australian record suggests that the information sought by authorities may not be sufficient for optimal pricing and that the economic evaluation of pharmaceuticals may be neither necessary nor sufficient for achieving this goal.
Original languageEnglish
Pages (from-to)267 - 272
Number of pages6
JournalAustralian Health Review
Issue number3
Publication statusPublished - 2011

Cite this